Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2019 | FY2021 | FY2022 | FY2023 | FY2024 | FY2026 |
|---|---|---|---|---|---|---|
| Revenue | $1.38B | $1.50B | $1.79B | $1.90B | $2.02B | $2.43B |
| Revenue growth | — | 8.0% | 19.6% | 6.0% | 6.8% | 20.2% |
| Gross profit | $419M | $455M | $553M | $595M | $636M | $810M |
| Gross margin | 30.3% | 30.4% | 30.9% | 31.4% | 31.4% | 33.3% |
| Operating income | $39.0M | -$3.49M | -$642M | $8.07M | $140M | $256M |
| Operating margin | 2.8% | -0.2% | -35.9% | 0.4% | 6.9% | 10.5% |
| Net income | -$76.5M | -$57.0M | -$662M | -$135M | -$10.9M | $225M |
| Net margin | -5.5% | -3.8% | -37.0% | -7.1% | -0.5% | 9.2% |
| EPS (diluted) | -$0.56 | -$0.40 | -$3.57 | -$0.71 | -$0.06 | $1.05 |
| Fiscal year | FY2019 | FY2021 | FY2022 | FY2023 | FY2024 | FY2026 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$8.71M | $117M | -$48.4M | $22.7M | $32.6M | $126M |
| Capital expenditures | $16.6M | $15.2M | $15.9M | — | — | — |
| Free cash flow | -$25.4M | $101M | -$64.4M | — | — | — |
| Fiscal year | FY2019 | FY2021 | FY2022 | FY2023 | FY2024 | FY2026 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | $137M | $19.2M | $43.9M | $84.3M | $193M |
| Total assets | — | $1.84B | $1.71B | $1.61B | $1.66B | $2.01B |
| Total liabilities | — | $1.58B | $1.72B | $1.74B | $1.79B | $1.82B |
| Long-term debt | — | $1.16B | $1.28B | $1.28B | $1.27B | $1.29B |
| Shareholders' equity | $270M | $265M | -$6.31M | -$130M | -$124M | $194M |
| Retained earnings | — | -$458M | -$1.24B | -$1.37B | -$1.38B | -$1.16B |
| Shares (wtd avg diluted) | — | 142M | 186M | 190M | 193M | 215M |
Every figure is extracted from Aveanna Healthcare Holdings, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.